Novartis AG (NVS) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Basel, Switzerland. The current CEO is Vasant Narasimhan.
NVS has IPO date of 1996-11-07, 75,883 full-time employees, listed on the NYSE, a market capitalization of $296.06B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets a broad portfolio of prescription medicines and healthcare products worldwide. The company operates through two primary segments: Innovative Medicines, which focuses on specialty pharmaceuticals across therapeutic areas including oncology, immunology, neuroscience, ophthalmology, cardiovascular, and respiratory diseases, and Sandoz, a leading generics and biosimilars business that produces small molecule pharmaceuticals, active pharmaceutical ingredients, and biotechnology-based products. Novartis maintains strategic partnerships and collaborations with biotechnology companies to advance its clinical pipeline and expand treatment options for patients globally.
